Literature DB >> 9698957

Porcine-derived surfactant treatment of severe bronchiolitis.

M Luchetti1, G Casiraghi, R Valsecchi, E Galassini, G Marraro.   

Abstract

BACKGROUND: It is hypothesized that surfactant treatment helps to improve severe bronchiolitis by restoring surfactant system activity. This study aims to assess the effect of surfactant on gas exchange, peak inspiratory pressure and duration of mechanical ventilation and intensive care unit (ICU) stay in children with severe bronchiolitis.
METHODS: Twenty children with bronchiolitis requiring mechanical ventilation were randomly assigned to one of two groups (10 patients each). Group A was treated with continuous positive pressure ventilation (CPPV) plus surfactant. Group B was treated with CPPV only. Porcine-derived surfactant, 50 mg/kg body weight, was instilled into the trachea. Arterial tension of oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio, arterial tension of carbon dioxide (PaCO2), and peak inspiratory pressure (PIP) were assessed. Heart rate and non-invasive arterial blood pressure were monitored. The duration of CPPV and the length of ICU stay were also recorded. Finally, the incidence of complications and the survival rate were assessed.
RESULTS: In group A, the PaO2/FiO2 ratio significantly improved from 1 h and a reduction in PaCO2 was noted from 12 h. A reduction of PIP was observed from 3 h. The duration of CPPV and the length of ICU stay were reduced in group A. No complications were reported in either group and all children survived.
CONCLUSIONS: Surfactant treatment of severe bronchiolitis appeared to improve gas exchange, reduce PIP and shorten CPPV and ICU stay. However, these initial results must be confirmed by a larger and more rigorously controlled study.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9698957     DOI: 10.1111/j.1399-6576.1998.tb05326.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  13 in total

Review 1.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

2.  Hyperoxia treatment of TREK-1/TREK-2/TRAAK-deficient mice is associated with a reduction in surfactant proteins.

Authors:  Andreas Schwingshackl; Benjamin Lopez; Bin Teng; Charlean Luellen; Florian Lesage; John Belperio; Riccardo Olcese; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

Review 3.  Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis.

Authors:  Caroline Davison; Kathleen M Ventre; Marco Luchetti; Adrienne G Randolph
Journal:  Pediatr Crit Care Med       Date:  2004-09       Impact factor: 3.624

Review 4.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Impaired recycling of surfactant-like liposomes in type II pneumocytes from injured lungs.

Authors:  B Müller; H Garn; R Hochscheid
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

Review 6.  Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.

Authors:  Nashwa El-Gendy; Anubhav Kaviratna; Cory Berkland; Prajnaparamita Dhar
Journal:  Ther Deliv       Date:  2013-08

Review 7.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

Review 8.  Surfactant therapy for bronchiolitis in critically ill infants.

Authors:  Kana R Jat; Deepak Chawla
Journal:  Cochrane Database Syst Rev       Date:  2015-08-24

Review 9.  Bench-to-bedside review: Paediatric viral lower respiratory tract disease necessitating mechanical ventilation--should we use exogenous surfactant?

Authors:  Martin C J Kneyber; Frans B Plötz; Jan L L Kimpen
Journal:  Crit Care       Date:  2005-10-05       Impact factor: 9.097

Review 10.  Surfactant therapy for acute respiratory failure in children: a systematic review and meta-analysis.

Authors:  Mark Duffett; Karen Choong; Vivian Ng; Adrienne Randolph; Deborah J Cook
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.